NCT06400550 Identification of Metabolic Phenotypes Associated With Melanoma Metastasis
| NCT ID | NCT06400550 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Texas Southwestern Medical Center |
| Condition | Melanoma (Skin) |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2018-08-01 |
| Primary Completion | 2028-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2018-08-01 with a primary completion date of 2028-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to observe metabolic features associated with human melanoma tumors.
Eligibility Criteria
Inclusion Criteria: * Patients with known or probable malignant melanoma lesions requiring surgical biopsy or excision. * Subjects of all races and ethnic origins over age 18. Exclusion Criteria: * Not a surgical candidate * Poorly controlled diabetes
Contact & Investigator
Jennifer Gill, MD, PhD
PRINCIPAL INVESTIGATOR
University of Texas Southwestern Medical Center
Frequently Asked Questions
Who can join the NCT06400550 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Melanoma (Skin). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06400550 currently recruiting?
Yes, NCT06400550 is actively recruiting participants. Contact the research team at aleuna.lee@utsouthwestern.edu for enrollment information.
Where is the NCT06400550 trial being conducted?
This trial is being conducted at Dallas, United States.
Who is sponsoring the NCT06400550 clinical trial?
NCT06400550 is sponsored by University of Texas Southwestern Medical Center. The principal investigator is Jennifer Gill, MD, PhD at University of Texas Southwestern Medical Center. The trial plans to enroll 400 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.